Out-of-hospital prophylaxis with low-molecular-weight heparin in hip surgery: The Swedish study

Chest

Volumn 114, Issue 2 SUPPL. 1, 1998, Pages

  Davidson, Bruce L ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; HIP SURGERY; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031867619     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Bergqvist D, Benoni G, Bjorgell O, et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996; 335:696-700
2. Planes A, Vochelle N, Darmon JY, et al. Risk of deep-venous thrombosis after hospital discharge in patients having under-gone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996; 348:224-228
3. Dahl OE, Andreassen G, Aspelin T, et al. Prolonged thromboprophylaxis following hip replacement surgery: results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 1997; 77:26-31
4. Serafini S, Beltrametti C, Siragusa S, et al. Post-thrombotic syndrome after asymptomatic postoperative deep vein thrombosis: an inception cohort study. Thromb Haemost 1997; 77(suppl):718